MetaCap

agilon health inc. Earnings

NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD

82.39-2.33 (-2.75%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

After market close

Fiscal period

Sep/2026

EPS estimate

$-2.01

agilon health inc. earnings summary

agilon health inc. is scheduled to report Sep/2026 earnings on Nov 4, 2026 after the market closes, with analysts expecting EPS of $-2.01. In its most recent report on Aug 5, 2026 (Q2 2026), AGL posted EPS of $1.04. Revenue for the quarter was $1.49 billion.

Across the last 16 reports, AGL shares moved an average of 13.1% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

AGL earnings history

agilon health inc. reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$1.04—+1.5%
May 6, 2026—$2.94—+50.7%
Feb 25, 2026—$5.71—+1.5%
Nov 4, 2025—$-0.27—-13.6%
Aug 4, 2025—$-6.31—+27.0%
May 6, 2025—$0.73—-15.2%
Feb 25, 2025—$-0.26—+12.5%
Nov 7, 2024—$-0.29—-14.1%
Aug 6, 2024—$-0.07—-12.1%
May 7, 2024—$0.01—+4.2%
Feb 27, 2024—$-0.40—-2.0%
Nov 2, 2023—$-0.06—-22.8%
Aug 3, 2023—$-0.04—-3.9%
May 9, 2023—$0.02—-9.5%
Mar 1, 2023—$-0.10—-9.4%
Nov 3, 2022—$-0.07—+9.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related